Luminex to Seek Slice of Newborn Screening Market This Year | GenomeWeb

By Edward Winnick

SAN FRANCISCO (GenomeWeb News) – Austin, Texas-based molecular diagnostics and multiplex instruments firm Luminex on Wednesday presented its plans to enter the newborn screening market over the next couple of years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.